Medical AI tool uncovers breast cancer signs in 11 women that doctors overlooked

Published On 2024-03-27 12:14 GMT   |   Update On 2024-03-27 12:14 GMT

In a groundbreaking advancement for cancer detection, a medical AI tool named Mia has emerged as a potential game-changer in the fight against breast cancer. Developed by the British firm Kheiron Medical Technologies, Mia showcased its prowess during a mass trial conducted within the UK's National Health Service (NHS). Covering 10,889 patients, the trial, implemented by NHS Grampian in...

Login or Register to read the full article

In a groundbreaking advancement for cancer detection, a medical AI tool named Mia has emerged as a potential game-changer in the fight against breast cancer. Developed by the British firm Kheiron Medical Technologies, Mia showcased its prowess during a mass trial conducted within the UK's National Health Service (NHS). Covering 10,889 patients, the trial, implemented by NHS Grampian in Scotland, harnessed the power of Microsoft's Azure cloud network for data analysis.

The efficacy of Mia became evident as it uncovered signs of breast cancer that had eluded human doctors, bringing to light 11 cases that had previously gone unnoticed. These cases included tumors too minuscule for even highly-trained radiologists to detect. Among those whose lives were potentially saved by Mia was Barbara, a resident of Aberdeen, Scotland, whose testimonial underscored the profound impact of the AI tool in catching her cancer at an early stage.


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News